References
Bartlett JW, Walker PL. Management of calcium channel blocker toxicity in the pediatric patient. J Pediatr Pharmacol Ther. 2019;24:378–89.
Harvey RD, Grant AO. Agents used in cardiac arrhythmias. In: Katzung BG, editor. Basic & clinical pharmacology. 14th ed. New York: McGraw-Hill; 2017. p. 228–53.
Schwartz JB, Nielsen AP, Griffin JC. Concentration-dependent enhancement of junctional pacemaker activity by verapamil in man. Circulation. 1985;71:450–7.
Pennock GD, Dalton WS, Roeske WR, et al. Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. J Natl Cancer Inst. 1991;83:105–10.
Kishore K, Raina A, Misra V, Jonas E. Acute verapamil toxicity in a patient with chronic toxicity: possible interaction with ceftriaxone and clindamycin. Ann Pharmacother. 1993;27:877–80.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Consent to Publish
Written informed consent for publication of their clinical details and/or clinical images was obtained from the patient/parent/guardian/ relative of the patient. A copy of the consent form is available for review by the Editor of this journal.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kohli, U., Lam, S., Eason, H. et al. Heart Rhythm Abnormalities Following Acute Verapamil Overdose. Indian J Pediatr 88, 285–286 (2021). https://doi.org/10.1007/s12098-020-03517-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-020-03517-3